Cited by 308Pancreatic function and diabetesDiabetes Treatment and ManagementGenetic Associations and Epidemiology

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms

Open access

Schäfer, S. A., Tschritter, O., Machicao, F., Thamer, C., Stefan, N., Gallwitz, B., Holst, J. J., Dekker, J. M., t’Hart, L. M., Nijpels, G., van Haeften, T. W., Häring, H. U., Fritsche, A.·2007·Diabetologia

DOI 10.1007/s00125-007-0753-6PMC PMC2063563

Open this paper in CoChat — free account Open PDF

Abstract

Aims/hypothesis Polymorphisms in the transcription factor 7-like 2 (TCF7L2) gene are associated with type 2 diabetes and reduced insulin secretion. The transcription factor TCF7L2 is an essential factor for glucagon-like peptide-1 (GLP-1) secretion from intestinal L cells. We studied whether a defect in the enteroinsular axis contributes to impaired insulin secretion in carriers of TCF7L2 polymorphisms.Methods We genotyped 1,110 non-diabetic German participants for five single nucleotide polymorphisms in TCF7L2. All participants underwent an OGTT; GLP-1 secretion was measured in 155 participants. In 210 participants, an IVGTT combined with a hyperinsulinaemic-euglycaemic clamp was performed. In another 160 participants from the Netherlands and 73 from Germany, a hyperglycaemic clamp (10 mmol/l) was performed. In 73 German participants this clamp was combined with a GLP-1 infusion and an arginine bolus.Results The OGTT data confirmed that variants in TCF7L2 are associated with reduced insulin secretion. In contrast, insulin secretion induced by an i.v. glucose challenge in the IVGTT and hyperglycaemic clamp was not different between the genotypes. GLP-1 concentrations during the OGTT were not influenced by the TCF7L2 variants. However, GLP-1-infusion combined with a hyperglycaemic clamp showed a significant reduction in GLP-1-induced insulin secretion in carriers of the risk allele in two variants (rs7903146, rs12255372, p < 0.02).Conclusions/interpretation Variants of TCF7L2 specifically impair GLP-1-induced insulin secretion. This seems to be rather the result of a functional defect in the GLP-1 signalling in beta cells than a reduction in GLP-1 secretion. This defect might explain the impaired insulin secretion in carriers of the risk alleles and confers the increased risk of type 2 diabetes.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1007/s00125-007-0753-6

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp
Matsuda, M., & DeFronzo, R. A. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1462 · Cited by 5,621
Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes
Grant, S. F. A., Thorleifsson, G., Reynisdottir, I., Benediktsson, R., Manolescu, A., Sainz, J., Helgason, A., Stefansson, H., Emilsson, V., Helgadottir, A., et al. (2006) · Nature Genetics · doi:10.1038/ng1732 · Cited by 2,287
TCF7L2 Polymorphisms and Progression to Diabetes in the Diabetes Prevention Program
Florez, J. C., Jablonski, K. A., Bayley, N., Pollin, T. I., de Bakker, P. I. W., Shuldiner, A. R., Knowler, W. C., Nathan, D. M., & Altshuler, D. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062418 · Cited by 834
Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo.
Deacon, C. F., Johnsen, A. H., & Holst, J. J. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.3.7883856 · Cited by 792
Self-citation
Glucagon-Like Peptide-1-(7–36)Amide Is Transformed to Glucagon-Like Peptide-1-(9–36)Amide by Dipeptidyl Peptidase IV in the Capillaries Supplying the L Cells of the Porcine Intestine1
Hansen, L., Deacon, C. F., Ørskov, C., & Holst, J. J. (1999) · Endocrinology · doi:10.1210/endo.140.11.7143 · Cited by 595
Self-citation
Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution
Helgason, A., Pálsson, S., Þorleifsson, G., Grant, S. F. A., Emilsson, V., Gunnarsdottir, S., Adeyemo, A., Chen, Y., Chen, G., Reynisdóttir, I., et al. (2007) · Nature Genetics · doi:10.1038/ng1960 · Cited by 529
TCF-4 Mediates Cell Type-specific Regulation of Proglucagon Gene Expression by β-Catenin and Glycogen Synthase Kinase-3β
Yi, F., Brubaker, P. L., & Jin, T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m411487200 · Cited by 417
WOMEN AND MEN
Scheinfeld, A. (1945) · The American Journal of the Medical Sciences · doi:10.1097/00000441-194507000-00025 · Cited by 381
Common Single Nucleotide Polymorphisms in TCF7L2 Are Reproducibly Associated With Type 2 Diabetes and Reduce the Insulin Response to Glucose in Nondiabetic Individuals
Saxena, R., Gianniny, L., Burtt, N. P., Lyssenko, V., Giuducci, C., Sjögren, M., Florez, J. C., Almgren, P., Isomaa, B., Orho‐Melander, M., et al. (2006) · Diabetes · doi:10.2337/db06-0381 · Cited by 373
The Peroxisome Proliferator-Activated Receptor-γ2 Pro12Ala Polymorphism
Stümvoll, M., & Häring, H. U. (2002) · Diabetes · doi:10.2337/diabetes.51.8.2341 · Cited by 329
Self-citation

Show all 30 references

Sorted by citations

Glucagon-like peptide 1 (GLP-1)
Müller, T. D., Finan, B., Bloom, S. R., D'Alessio, D., Drucker, D. J., Flatt, P. R., Fritsche, A., Gribble, F., Grill, H. J., Habener, J. F., et al. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.09.010 · Cited by 1,868
Self-citation
GLP-1 receptor agonists in the treatment of type 2 diabetes - state-of-the-art
Nauck, M. A., Quast, D. R., Wefers, J., & Meier, J. J. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101102 · Cited by 1,647
“Along these lines, certain polymorphisms regarding the TCF7L2 gene (probably involved in determining b cell mass and the expression of GLP-1 receptors) impair insulin responses to exogenous GLP-1 [216].”
Background
Pharmacology, physiology, and mechanisms of incretin hormone action.
Campbell, J. E., & Drucker, D. J. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.04.008 · Cited by 1,500
Using multiple genetic variants as instrumental variables for modifiable risk factors
Palmer, T. M., Lawlor, D. A., Harbord, R. M., Sheehan, N. A., Tobias, J. H., Timpson, N. J., Smith, G. D., & Sterne, J. A. (2012) · Statistical Methods in Medical Research · doi:10.1177/0962280210394459 · Cited by 1,289
Physiology of Proglucagon Peptides: Role of Glucagon and GLP-1 in Health and Disease
Sandoval, D. A., & D'Alessio, D. A. (2015) · Physiological Reviews · doi:10.1152/physrev.00013.2014 · Cited by 498
Genetics of type 2 diabetes
Ali, O. (2013) · World Journal of Diabetes · doi:10.4239/wjd.v4.i4.114 · Cited by 350
Newly identified loci highlight beta cell dysfunction as a key cause of type 2 diabetes: Where are the insulin resistance genes?
Florez, J. C. (2008) · Diabetologia · doi:10.1007/s00125-008-1025-9 · Cited by 299
Loss of Incretin Effect Is a Specific, Important, and Early Characteristic of Type 2 Diabetes
Holst, J. J., Knop, F. K., Vilsbøll, T., Krarup, T., & Madsbad, S. (2011) · Diabetes Care · doi:10.2337/dc11-s227 · Cited by 289
Self-citation
Decreased TCF7L2 protein levels in type 2 diabetes mellitus correlate with downregulation of GIP- and GLP-1 receptors and impaired beta-cell function
Shu, L., Matveyenko, A. V., Kerr-Conte, J. A., Cho, J., McIntosh, C. H. S., & Maedler, K. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp178 · Cited by 269
Transcription Factor 7-Like 2 Regulates β-Cell Survival and Function in Human Pancreatic Islets
Shu, L., Sauter, N. S., Schulthess, F. T., Matveyenko, A. V., Oberholzer, J., & Maedler, K. (2007) · Diabetes · doi:10.2337/db07-0847 · Cited by 263
Retracted
Polymorphisms in the TCF7L2, CDKAL1 and SLC30A8 genes are associated with impaired proinsulin conversion
Kirchhoff, K., Machicao, F. E., Haupt, A., Schäfer, S., Tschritter, O., Staiger, H., Stefan, N., Häring, H.-U., & Fritsche, A. (2008) · Diabetologia · doi:10.1007/s00125-008-0926-y · Cited by 264
Self-citation
Glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1: Incretin actions beyond the pancreas
Seino, Y., & Yabe, D. (2013) · Journal of Diabetes Investigation · doi:10.1111/jdi.12065 · Cited by 255
Weight loss variability with SGLT2 inhibitors and GLP‐1 receptor agonists in type 2 diabetes mellitus and obesity: Mechanistic possibilities
Brown, E. E., Wilding, J. P. H., Barber, T. M., Alam, U., & Cuthbertson, D. J. (2019) · Obesity Reviews · doi:10.1111/obr.12841 · Cited by 226
Is the Diminished Incretin Effect in Type 2 Diabetes Just an Epi-Phenomenon of Impaired β-Cell Function?
Meier, J. J., & Nauck, M. A. (2010) · Diabetes · doi:10.2337/db09-1899 · Cited by 215
Lipotoxicity disrupts incretin-regulated human β cell connectivity
Hodson, D. J., Mitchell, R. K., Bellomo, E. A., Sun, G., Vinet, L., Meda, P., Li, D., Li, W.-H., Bugliani, M., Marchetti, P., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci68459 · Cited by 210
Type of fatty acids in maternal diets during pregnancy and/or lactation and metabolic consequences of the offspring
Mennitti, L. V., de Oliveira, J. L., Morais, C. A., Estadella, D., Oyama, L. M., do Nascimento, C. M. O., & Pisani, L. P. (2014) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2014.10.001 · Cited by 208
The WNT signalling pathway and diabetes mellitus
Jin, T. (2008) · Diabetologia · doi:10.1007/s00125-008-1084-y · Cited by 211
Minireview: The Wnt Signaling Pathway Effector TCF7L2 and Type 2 Diabetes Mellitus
Jin, T., & Liu, L. (2008) · Molecular Endocrinology · doi:10.1210/me.2008-0135 · Cited by 194
Physiology of incretins (GIP and GLP-1) and abnormalities in type 2 diabetes
Gautier, J. F., Choukem, S. P., & Girard, J. R. (2008) · Diabetes & Metabolism · doi:10.1016/s1262-3636(08)73397-4 · Cited by 186
Association of 18 Confirmed Susceptibility Loci for Type 2 Diabetes With Indices of Insulin Release, Proinsulin Conversion, and Insulin Sensitivity in 5,327 Nondiabetic Finnish Men
Stančáková, A., Kuulasmaa, T., Paananen, J., Jackson, A., Bonnycastle, L. L., Collins, F. S., Boehnke, M., Kuusisto, J., & Laakso, M. (2009) · Diabetes · doi:10.2337/db09-0117 · Cited by 171
Genetics of Type 2 Diabetes
Ahlqvist, E., Ahluwalia, T. S., & Groop, L. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.157016 · Cited by 166
Wnt signaling: relevance to β-cell biology and diabetes
Welters, H. J., & Kulkarni, R. (2008) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2008.08.004 · Cited by 172
Glucagon-like peptide-1, glucose homeostasis and diabetes
Holst, J. J., Deacon, C. F., Vilsbøll, T., Krarup, T., & Madsbad, S. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2008.01.003 · Cited by 162
Self-citation
TCF7L2 Variant rs7903146 Affects the Risk of Type 2 Diabetes by Modulating Incretin Action
Villareal, D. T., Robertson, H., Bell, G. I., Patterson, B. W., Tran, H. D., Wice, B. M., & Polonsky, K. S. (2009) · Diabetes · doi:10.2337/db09-1169 · Cited by 162
Molecular mechanisms underlying nutrient-stimulated incretin secretion
Parker, H. E., Reimann, F., & Gribble, F. M. (2010) · Expert Reviews in Molecular Medicine · doi:10.1017/s146239940900132x · Cited by 155
Causes of type 2 diabetes in China
Ronald, C. W., Xu, L., & Jia, W. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70145-7 · Cited by 158
Non-alcoholic fatty liver disease and type 2 diabetes mellitus: the liver disease of our age?
Firneisz, G. (2014) · PubMed Central · doi:10.3748/wjg.v20.i27.9072 · Cited by 148
Targeting the glucagon receptor family for diabetes and obesity therapy
Cho, Y. M., Merchant, C. E., & Kieffer, T. J. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.05.009 · Cited by 144
The T allele of rs7903146 TCF7L2 is associated with impaired insulinotropic action of incretin hormones, reduced 24 h profiles of plasma insulin and glucagon, and increased hepatic glucose production in young healthy men
Pilgaard, K. A., Jensen, C. B., Schou, J. H., Lyssenko, V., Wegner, L., Brøns, C., Vilsbøll, T., Hansen, T. F., Madsbad, S., Holst, J. J., et al. (2009) · Diabetologia · doi:10.1007/s00125-009-1307-x · Cited by 145
Self-citation
Gene Variants in the Novel Type 2 Diabetes Loci CDC123/CAMK1D, THADA, ADAMTS9, BCL11A, and MTNR1B Affect Different Aspects of Pancreatic β-Cell Function
Simonis-Bik, A. M. C., Nijpels, G., van Haeften, T. W., Houwing‐Duistermaat, J. J., Boomsma, D. I., Reiling, E., van Hove, E. C., Diamant, M., Kramer, M. H. H., Heine, R. J., et al. (2009) · Diabetes · doi:10.2337/db09-1048 · Cited by 139
Self-citation
Variants of CDKAL1 and IGF2BP2 affect first-phase insulin secretion during hyperglycaemic clamps
Groenewoud, M. J., Dekker, J. M., Fritsche, A., Reiling, E., Nijpels, G., Heine, R. J., Maassen, J. A., Machicao, F. E., Schäfer, S., Häring, H., et al. (2008) · Diabetologia · doi:10.1007/s00125-008-1083-z · Cited by 135
Self-citation
Pathomechanisms of Type 2 Diabetes Genes
Staiger, H., Machicao, F. E., Fritsche, A., & Häring, H.-U. (2009) · Endocrine Reviews · doi:10.1210/er.2009-0017 · Cited by 141
Self-citation
Current Understanding on Role of the Wnt Signaling Pathway Effector TCF7L2 in Glucose Homeostasis
Jin, T. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1146 · Cited by 132
Minireview: Update on Incretin Biology: Focus on Glucagon-Like Peptide-1
Brubaker, P. L. (2010) · Endocrinology · doi:10.1210/en.2010-0115 · Cited by 122
The involvement of the wnt signaling pathway and TCF7L2 in diabetes mellitus: The current understanding, dispute, and perspective
Ip, W., Chiang, Y.-T. A., & Jin, T. (2012) · Cell & Bioscience · doi:10.1186/2045-3701-2-28 · Cited by 115
A Genome-Wide Association Study of IVGTT-Based Measures of First-Phase Insulin Secretion Refines the Underlying Physiology of Type 2 Diabetes Variants
Wood, A. R., Jonsson, A., Jackson, A. U., Wang, N., van Leewen, N., Palmer, N. D., Kobes, S., Deelen, J., Boquete-Vilarino, L., Paananen, J., et al. (2017) · Diabetes · doi:10.2337/db16-1452 · Cited by 117
Self-citation
Polymorphisms within the Novel Type 2 Diabetes Risk Locus MTNR1B Determine β-Cell Function
Staiger, H., Machicao, F. E., Schäfer, S., Kirchhoff, K., Kantartzis, K., Guthoff, M., Silbernagel, G., Stefan, N., Häring, H., & Fritsche, A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003962 · Cited by 116
Self-citation
The Genetics of Type 2 Diabetes: A Realistic Appraisal in 2008
Florez, J. C. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1345 · Cited by 118
The Wnt Signaling Pathway Effector TCF7L2 Controls Gut and Brain Proglucagon Gene Expression and Glucose Homeostasis
Shao, W., Wang, D., Chiang, Y., Ip, W., Zhu, L., Xu, F., Columbus, J., Belsham, D. D., Irwin, D. M., Zhang, H., et al. (2012) · Diabetes · doi:10.2337/db12-0365 · Cited by 118
Genome-wide analysis of PDX1 target genes in human pancreatic progenitors
Wang, X., Sterr, M., Burtscher, I., Chen, S., Hieronimus, A., Machicao, F. E., Staiger, H., Häring, H., Lederer, G., Meitinger, T., et al. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.01.011 · Cited by 110
Self-citation
Therapy in the Early Stage: Incretins
Cernea, S., & Raz, I. (2011) · Diabetes Care · doi:10.2337/dc11-s223 · Cited by 114
Abnormal glucose tolerance and insulin secretion in pancreas-specific Tcf7l2-null mice
Xavier, G. D. S., Mondragon, A., Sun, G., Chen, L., McGinty, J., French, P. M. W., & Rutter, G. A. (2012) · Diabetologia · doi:10.1007/s00125-012-2600-7 · Cited by 111
Association of Type 2 Diabetes Candidate Polymorphisms in KCNQ1 With Incretin and Insulin Secretion
Müssig, K., Staiger, H., Machicao, F. E., Kirchhoff, K., Guthoff, M., Schäfer, S., Kantartzis, K., Silbernagel, G., Stefan, N., Holst, J. J., et al. (2009) · Diabetes · doi:10.2337/db08-1589 · Cited by 110
Self-citation
Tissue-specific alternative splicing of TCF7L2
Prokunina‐Olsson, L., Welch, C., Hansson, O., Adhikari, N., Scott, L. J., Usher, N., Tong, M., Sprau, A. G., Swift, A. J., Bonnycastle, L. L., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp321 · Cited by 105
Association between insulin secretion, insulin sensitivity and type 2 diabetes susceptibility variants identified in genome-wide association studies
Ruchat, S.-M., Elks, C. E., Loos, R. J. F., Vohl, M., Weisnagel, S. J., Rankinen, T., Bouchard, C., & Përusse, L. (2008) · Acta Diabetologica · doi:10.1007/s00592-008-0080-5 · Cited by 107
Selective disruption of Tcf7l2 in the pancreatic β cell impairs secretory function and lowers β cell mass
Mitchell, R. K., Mondragon, A., Chen, L., McGinty, J., French, P. M. W., Ferrer, J. P., Thorens, B., Hodson, D. J., Rutter, G. A., & Xavier, G. D. S. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu553 · Cited by 103
Whole-grain consumption and transcription factor-7-like 2 (TCF7L2) rs7903146: gene–diet interaction in modulating type 2 diabetes risk
Fisher, E., Boeing, H., Fritsche, A., Doering, F., Joost, H., & Schulze, M. B. (2008) · British Journal Of Nutrition · doi:10.1017/s0007114508020369 · Cited by 100
Self-citation
Pharmacogenetics of type 2 diabetes mellitus, the route toward tailored medicine
Mannino, G. C., Andreozzi, F., & Sesti, G. (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3109 · Cited by 108
The rs7903146 Variant in the TCF7L2 Gene Increases the Risk of Prediabetes/Type 2 Diabetes in Obese Adolescents by Impairing β-Cell Function and Hepatic Insulin Sensitivity
Cropano, C. M., Santoro, N., Groop, L., Man, C. D., Cobelli, C., Galderisi, A., Kursawe, R., Pierpont, B. M., Goffredo, M., & Caprio, S. (2017) · Diabetes Care · doi:10.2337/dc17-0290 · Cited by 94
Targeted deletion of Tcf7l2 in adipocytes promotes adipocyte hypertrophy and impaired glucose metabolism
Geoghegan, G., Simcox, J., Seldin, M. M., Parnell, T. J., Stubben, C., Just, S. F., Begaye, L. J., Lusis, A. J., & Villanueva, C. J. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.03.003 · Cited by 90
Wnt Signaling in Pancreatic Islets
Liu, Z., & Habener, J. F. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-90-481-3271-3_17 · Cited by 94
K-cells and Glucose-Dependent Insulinotropic Polypeptide in Health and Disease
Cho, Y. M., & Kieffer, T. J. (2010) · Vitamins and hormones · doi:10.1016/b978-0-12-381517-0.00004-7 · Cited by 98
Association of TCF7L2 polymorphisms with susceptibility to type 2 diabetes in 4,087 Japanese subjects
Miyake, K., Horikawa, Y., Hara, K., Yasuda, K., Osawa, H., Furuta, H., Hirota, Y., Yamagata, K., Hinokio, Y., Oka, Y., et al. (2007) · Journal of Human Genetics · doi:10.1007/s10038-007-0231-5 · Cited by 91
Mechanisms underlying proglucagon gene expression
Jin, T. (2008) · Journal of Endocrinology · doi:10.1677/joe-08-0085 · Cited by 93
A common genetic variant in WFS1 determines impaired glucagon-like peptide-1-induced insulin secretion
Schäfer, S., Müssig, K., Staiger, H., Machicao, F. E., Stefan, N., Gallwitz, B., Häring, H.-U., & Fritsche, A. (2009) · Diabetologia · doi:10.1007/s00125-009-1344-5 · Cited by 89
Self-citation
TCF7L2 genetic defect and type 2 diabetes
Cauchi, S., & Froguel, P. (2008) · Current Diabetes Reports · doi:10.1007/s11892-008-0026-x · Cited by 91
Gene Variants of TCF7L2 Influence Weight Loss and Body Composition During Lifestyle Intervention in a Population at Risk for Type 2 Diabetes
Haupt, A., Thamer, C., Heni, M., Ketterer, C., Machann, J., Schick, F., Machicao, F. E., Stefan, N., Claussen, C. D., Häring, H., et al. (2009) · Diabetes · doi:10.2337/db09-1050 · Cited by 86
Self-citation
TCF7L2, dietary carbohydrate, and risk of type 2 diabetes in US women
Cornelis, M. C., Qi, L., Kraft, P. L., & Hu, F. B. (2009) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.27058 · Cited by 90
New type 2 diabetes risk genes provide new insights in insulin secretion mechanisms
Schäfer, S., Machicao, F. E., Fritsche, A., Häring, H., & Kantartzis, K. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(11)70008-0 · Cited by 80
Self-citation
β-cell failure in type 2 diabetes mellitus
Lencioni, C., Lupi, R., & Prato, S. D. (2008) · Current Diabetes Reports · doi:10.1007/s11892-008-0031-0 · Cited by 78
TCF7L2 rs7903146–macronutrient interaction in obese individuals’ responses to a 10-wk randomized hypoenergetic diet
Grau, K., Cauchi, S., Holst, C., Astrup, A. V., Martínez, J. A., Saris, W. H. M., Blaak, E. E., Oppert, J., Arner, P., Rössner, S., et al. (2009) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.27947 · Cited by 77
The TCF7L2 Locus: A Genetic Window Into the Pathogenesis of Type 1 and Type 2 Diabetes
Grant, S. F. A. (2019) · Diabetes Care · doi:10.2337/dci19-0001 · Cited by 81
Effect of Diet Quality and Genetic Predisposition on Hemoglobin A1c and Type 2 Diabetes Risk: Gene-Diet Interaction Analysis of 357,419 Individuals
Zhuang, P., Liu, X., Li, Y., Wan, X., Wu, Y., Wu, F., Zhang, Y., & Jiao, J. (2021) · Diabetes Care · doi:10.2337/dc21-1051 · Cited by 75
Genotype and Tissue-Specific Effects on Alternative Splicing of the Transcription Factor 7-Like 2 Gene in Humans
Mondal, A. K., Das, S. K., Baldini, G., Chu, W. S., Sharma, N., Hackney, O. G., Zhao, J., Grant, S. F. A., & Elbein, S. C. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2064 · Cited by 70
TCF7L2 rs7903146 impairs islet function and morphology in non-diabetic individuals
Bacquer, O. L., Kerr-Conte, J. A., Gargani, S., Delalleau, N., Huyvaert, M., Gmyr, V., Froguel, P., NEVE, B. P., & Pattou, F. N. (2012) · Diabetologia · doi:10.1007/s00125-012-2660-8 · Cited by 71
TCF7L2 splice variants have distinct effects on β-cell turnover and function
Bacquer, O. L., Shu, L., Marchand, M., NEVE, B. P., Paroni, F., Kerr-Conte, J., Pattou, F. N., Froguel, P., & Maedler, K. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr072 · Cited by 71
TCF7L2 controls insulin gene expression and insulin secretion in mature pancreatic β-cells
Loder, M. K., Xavier, G. D. S., McDonald, A., & Rutter, G. A. (2008) · Biochemical Society Transactions · doi:10.1042/bst0360357 · Cited by 69
The Wnt signaling pathway effector TCF7L2 is upregulated by insulin and represses hepatic gluconeogenesis
Ip, W., Shao, W., Chiang, Y.-T. A., & Jin, T. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00249.2012 · Cited by 77
Impact ofTCF7L2rs7903146 on Insulin Secretion and Action in Young and Elderly Danish Twins
Thørner, L. W., Hussain, M. S., Pilgaard, K. A., Hansen, T. F., Pedersen, O. B., Vaag, A. A., & Poulsen, P. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0855 · Cited by 65
Molecular Function of TCF7L2: Consequences of TCF7L2 Splicing for Molecular Function and Risk for Type 2 Diabetes
Hansson, O., Zhou, Y., Renström, E., & Osmark, P. (2010) · Current Diabetes Reports · doi:10.1007/s11892-010-0149-8 · Cited by 67
The future of incretin‐based therapy: novel avenues—novel targets
Åhrén, B. (2011) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01457.x · Cited by 62
Evaluation of Fasting State-/Oral Glucose Tolerance Test-Derived Measures of Insulin Release for the Detection of Genetically Impaired β-Cell Function
Herzberg-Schäfer, S. A., Staiger, H., Heni, M., Ketterer, C., Guthoff, M., Kantartzis, K., Machicao, F. E., Stefan, N., Häring, H., & Fritsche, A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014194 · Cited by 62
Self-citation
Beta cell connectivity in pancreatic islets: a type 2 diabetes target?
Rutter, G. A., & Hodson, D. J. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1755-4 · Cited by 62
Influence of TCF7L2 gene variants on the therapeutic response to the dipeptidylpeptidase-4 inhibitor linagliptin
Zimdahl, H., Ittrich, C., Graefe‐Mody, U., Boehm, B. O., Mark, M., Woerle, H., & Dugi, K. A. (2014) · Diabetologia · doi:10.1007/s00125-014-3276-y · Cited by 61
Association of variants of the TCF7L2 gene with increases in the risk of type 2 diabetes and the proinsulin:insulin ratio in the Spanish population
González‐Sánchez, J. L., Martínez-Larrad, M. T., Aben, K. K. H., Pérez‐Barba, M., & Serrano‐Ríos, M. (2008) · Diabetologia · doi:10.1007/s00125-008-1129-2 · Cited by 60
The Expression of Aldolase B in Islets Is Negatively Associated With Insulin Secretion in Humans
Gerst, F., Jaghutriz, B. A., Staiger, H., Schulte, A. M., Lorza‐Gil, E., Kaiser, G., Panse, M., Haug, S., Heni, M., Schütz, M., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00791 · Cited by 55
Self-citation
Dietary Effects on Incretin Hormone Secretion
Wu, T., Rayner, C. K., Jones, K. L., & Horowitz, M. (2010) · Vitamins and hormones · doi:10.1016/b978-0-12-381517-0.00003-5 · Cited by 58
Impairment of GLP1 ‐induced insulin secretion: role of genetic background, insulin resistance and hyperglycaemia
Herzberg-Schäfer, S. A., Heni, M., Stefan, N., Häring, H., & Fritsche, A. (2012) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2012.01648.x · Cited by 59
Self-citation
TCF7L2 Genotype and α-Cell Function in Humans Without Diabetes
Shah, M., Varghese, R. T., Miles, J. M., Piccinini, F., Man, C. D., Cobelli, C., Bailey, K. R., Rizza, R. A., & Vella, A. V. (2015) · Diabetes · doi:10.2337/db15-1233 · Cited by 58
Genetic Variants ofTCF7L2Are Associated with Insulin Resistance and Related Metabolic Phenotypes in Taiwanese Adolescents and Caucasian Young Adults
Liu, P., Chang, Y., Jiang, Y., Chen, W. J., Chang, T., Kuo, S., Lee, K., Hsiao, P., Chiu, K. C., & Chuang, L. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0609 · Cited by 57
Liver-Specific Expression of Dominant-Negative Transcription Factor 7-Like 2 Causes Progressive Impairment in Glucose Homeostasis
Ip, W., Shao, W., Song, Z., Chen, Z., Wheeler, M. B., & Jin, T. (2015) · Diabetes · doi:10.2337/db14-1329 · Cited by 58
Glucagon and Glucagon-Like Peptides 1 and 2
Holst, J. J. (2009) · Results and problems in cell differentiation · doi:10.1007/400_2009_35 · Cited by 53
Self-citation
The role of the Wnt signaling pathway in incretin hormone production and function
Chiang, Y., Ip, W., & Jin, T. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00273 · Cited by 59
Physiologic Characterization of Type 2 Diabetes–Related Loci
Grarup, N., Sparsø, T., & Hansen, T. F. (2010) · Current Diabetes Reports · doi:10.1007/s11892-010-0154-y · Cited by 54
Incretin actions beyond the pancreas: lessons from knockout mice
Yabe, D., & Seino, Y. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.09.013 · Cited by 54
Combined Risk Allele Score of Eight Type 2 Diabetes Genes Is Associated With Reduced First-Phase Glucose-Stimulated Insulin Secretion During Hyperglycemic Clamps
Hart, L. M. ‘., Simonis-Bik, A. M. C., Nijpels, G., van Haeften, T. W., Schäfer, S., Houwing‐Duistermaat, J. J., Boomsma, D. I., Groenewoud, M. J., Reiling, E., van Hove, E. C., et al. (2009) · Diabetes · doi:10.2337/db09-0736 · Cited by 53
Self-citation
Novel phenotypes of prediabetes?
Häring, H. (2016) · Diabetologia · doi:10.1007/s00125-016-4015-3 · Cited by 54
Self-citation
TCF7L2 promotes beta cell regeneration in human and mouse pancreas
Shu, L., Zien, K. S., Gutjahr, G., Oberholzer, J., Pattou, F. N., Kerr-Conte, J. A., & Maedler, K. (2012) · Diabetologia · doi:10.1007/s00125-012-2693-z · Cited by 53
Polymorphisms of GLP-1 Receptor Gene and Response to GLP-1 Analogue in Patients with Poorly Controlled Type 2 Diabetes
Lin, C.-H., Lee, Y., Huang, Y., Hsieh, S., Chen, Z.-S., & Tsai, C. (2015) · Journal of Diabetes Research · doi:10.1155/2015/176949 · Cited by 51
Integrative network analysis highlights biological processes underlying GLP-1 stimulated insulin secretion: A DIRECT study
Guðmundsdóttir, V., Pedersen, H., Allebrandt, K. V., Brorsson, C., van Leeuwen, N., Banasik, K., Mahajan, A., Groves, C. J., van de Bunt, M., Dawed, A. Y., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0189886 · Cited by 50
Self-citation
TCF7L2 Genetic Variation Augments Incretin Resistance and Influences Response to a Sulfonylurea and Metformin: The Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans (SUGAR-MGH)
Srinivasan, S., Kaur, V., Chamarthi, B., Littleton, K. R., Chen, L., Manning, A. K., Merino, J., Thomas, M. K., Hudson, M., Goldfine, A. B., et al. (2018) · Diabetes Care · doi:10.2337/dc17-1386 · Cited by 51
Pharmacogenetics of novel glucose-lowering drugs
Rathmann, W., & Bongaerts, B. W. C. (2021) · Diabetologia · doi:10.1007/s00125-021-05402-w · Cited by 52
The Sum of Many Parts: Potential Mechanisms for Improvement in Glucose Homeostasis After Bariatric Surgery
Nguyen, K. T., & Körner, J. (2014) · Current Diabetes Reports · doi:10.1007/s11892-014-0481-5 · Cited by 48
Genetic variation within the TRPM5 locus associates with prediabetic phenotypes in subjects at increased risk for type 2 diabetes
Ketterer, C., Müssig, K., Heni, M., Dudziak, K., Randrianarisoa, E., Wagner, R. J., Machicao, F. E., Stefan, N., Holst, J. J., Fritsche, A., et al. (2011) · Metabolism · doi:10.1016/j.metabol.2011.02.002 · Cited by 47
Self-citation
Glycemia Determines the Effect of Type 2 Diabetes Risk Genes on Insulin Secretion
Heni, M., Ketterer, C., Thamer, C., Herzberg-Schäfer, S. A., Guthoff, M., Stefan, N., Machicao, F. E., Staiger, H., Fritsche, A., & Häring, H. (2010) · Diabetes · doi:10.2337/db10-0674 · Cited by 47
Self-citation
Pharmacogenetics of Oral Antidiabetic Drugs
Becker, M. L., Pearson, E. R., & Tkáč, I. (2013) · International Journal of Endocrinology · doi:10.1155/2013/686315 · Cited by 48
Type 2 Diabetes Mellitus
Polonsky, K. S., & Burant, C. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00031-9 · Cited by 53
Pathophysiological aspects of Wnt-signaling in endocrine disease
Schinner, S., Willenberg, H. S., Schott, M., & Scherbaum, W. A. (2009) · European Journal of Endocrinology · doi:10.1530/eje-08-0831 · Cited by 47
Genetic variants affecting incretin sensitivity and incretin secretion
Müssig, K., Staiger, H., Machicao, F. E., Häring, H., & Fritsche, A. (2010) · Diabetologia · doi:10.1007/s00125-010-1876-8 · Cited by 47
Self-citation
A model of GLP-1 action on insulin secretion in nondiabetic subjects
Dalla Man, C., Micheletto, F., Sathananthan, A., Rizza, R. A., Vella, A., & Cobelli, C. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00705.2009 · Cited by 45

Authors: Schäfer, S. A., Tschritter, O., Machicao, F., Thamer, C., Stefan, N., Gallwitz, B., Holst, J. J., Dekker, J. M., t’Hart, L. M., Nijpels, G., van Haeften, T. W., Häring, H. U., & Fritsche, A.
Affiliations: University of Tübingen (DE)
University of Copenhagen (DK)
Amsterdam Public Health (NL)
Corresponding author: Fritsche, A.
ORCID: Stefan, N.
Gallwitz, B.
Holst, J. J.
Nijpels, G.
Fritsche, A.
Venue: Diabetologia
Publisher: Springer Science and Business Media LLC
Published: 2007-07-28
Volume: 50
Issue: 12
Pages: 2443-2450
ISSN: 0012-186X (ISSN-L)
1432-0428
DOI: 10.1007/s00125-007-0753-6
PMC: PMC2063563
OpenAlex: W2132717133
Cited by: 308
References: 30
Citations by year: 2026: 3 · 2025: 5 · 2024: 7 · 2023: 5 · 2022: 9 · 2021: 8 · 2020: 11 · 2019: 18 · 2018: 14 · 2017: 10 · 2016: 15 · 2015: 15 · 2014: 26 · 2013: 17 · 2012: 23
FWCI: 32.85
Type: journal article
Language: en
Update notices: correction (2007-11-10)
correction (2009-01-08)
Open access: bronze
doi.org
Licence: www.springer.com/tdm (tdm)
Locations: Diabetologia (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
VU Research Portal (publishedVersion, other-oa)
Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam) (submittedVersion)
Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
Funders: Deutsche Forschungsgemeinschaft (KFO 114)
ZonMw
Centre for Medical Systems Biology
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
Keywords: TCF7L2, glucagon-like peptide-1, insulin secretion, type 2 diabetes risk, single nucleotide polymorphisms, enteroinsular axis, GLP-1 secretion, GLP-1 receptor, rs7903146, rs12255372, risk alleles
MeSH terms: Insulin Secretion, Adult, Arginine, Blood Glucose, Female, Glucose Tolerance Test, Heterozygote, Humans, Insulin, Insulin Resistance, Male, Middle Aged, Glucose Clamp Technique, Glucose Intolerance, Polymorphism, Single Nucleotide, TCF Transcription Factors, Glucagon-Like Peptide 1, Transcription Factor 7-Like 2 Protein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks